CVS Health's David Joyner is expected to address how he will better manage rising patient costs in the Medicare business than his predecessor when he tackles his first earnings call as CEO on Wednesday, particularly after rivals have shown progress on that front in recent financial reports.
CVS Health (CVS) will report third-quarter earnings before the market opens Wednesday after the pharmacy and health-care provider had a rocky October that included a CEO change and layoffs, among other cost-cutting moves.
CNBC's Jim Cramer highlighted the Federal Reserve's next meeting and earnings from Berkshire Hathaway and Super Micro Computer. He said Wall Street will hone in on the outcome of the highly contentious presidential election.
NEW YORK, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against CVS Health Corporation (NYSE: CVS) on behalf of long-term stockholders following a class action complaint that was filed against CVS on July 12, 2024 with a Class Period from May 3, 2023 to April 30, 2024. Our investigation conce...
CVS Health dropped ~10% following Q3 earnings, impacted by a $1.1B Medicare charge and a $1.2B restructuring charge. CVS's FY2024 EPS forecast is $6.47, down 26.01% YoY, reflecting financial challenges, but FY2025 recovery is projected at $7.30, up 13%. The company's revenue is estimated at $369.25 billion in 2024, with upward revisions suggesting optimism, projected to reach $386.28 billion by...
Foundation announces $1.5 million in new Health Zones funding and progress through first six months of the program WOONSOCKET, R.I. , Oct. 23, 2024 /PRNewswire/ -- The CVS Health® Foundation today announced $1.5 million in new Health Zones funding between Good Samaritan Health Center, Open Hand Atlanta and Uber Health to increase access to comprehensive health care services, medically tailored ...
Walmart said Tuesday that it will start delivering prescriptions to customers' doorsteps. The discounter will start with six states, but plans to offer prescription delivery in 49 states by the end of January.
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.